Our Managing Director, Dr. Sanjay Singh, participated in a distinguished panel at the BioEconomy Conclave 2025, where he spoke on 'Focusing on Emerging Technologies in Shaping the World.' He shared his insights on the potential of India becoming a global manufacturing hub for gene therapies, contributing significantly to India's bioeconomy, which is projected to grow to $300 billion USD in the next five years, capturing a 20% stake in the global bioeconomy of $1.5 trillion USD.